Patent Thicket Remedies

Patent Thicket Remedies

Yesterday, the Initiative for Medicines, Access, and Knowledge I-MAK took an important step by proposing six policy solutions to address patent thickets that block generic and biosimilar drug competition.

The State of Biosimilars: What to Watch

The State of Biosimilars: What to Watch

Now that biosimilar versions of Humira are starting to arrive, what happens next? Will this finally prove the case that biosimilars can deliver on big health care savings?